Search Within

Adam D Cohen

Formats
  1. Meeting Abstract (22)
  2. Journal Article (19)
  3. Book Section (2)
  4. Book Whole (1)
Groups
  1. Department of Medicine (44)
  2. Hematologic Malignancies, Division of (35)
  3. Center for Hematologic Malignancies (28)
  4. Solid Tumor Oncology Division (21)
  5. GSK Faculty (20)
  6. Melanoma and Immunotherapeutics Service (19)

More Groups

People
  1. Raymond Comenzo (21)
  2. Jedd Wolchok (19)
  3. Hani Hassoun (16)
  4. Alan Houghton (15)
  5. Stephen Nimer (15)
  6. Martin Fleisher (13)

More People

Years
  1. 2021 (1)
  2. 2018 (1)
  3. 2013 (1)
  4. 2011 (1)
  5. 2010 (1)
  6. 2009 (4)

More Years

Publications
  1. Blood (14)
  2. Cancer Research (5)
  3. British Journal of Haematology (4)
  4. Journal of Clinical Oncology (3)
  5. PLoS ONE (3)
  6. Amyloid (1)

More Publications

Publishers
  1. American Society of Hematology (14)
  2. American Association for Cancer Research (5)
  3. John Wiley & Sons (4)
  4. American Society of Clinical Oncology (3)
  5. Elsevier Inc. (3)
  6. Public Library of Science (3)

More Publishers

Results (44)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cyclophosphamide enhances the antitumor potency of GITR engagement by increasing oligoclonal cytotoxic T cell fitness
    Journal Article

    Hirschhorn, D.; Betof Warner, A.; Maniyar, R.; Chow, A.; Mangarin, L. M. B.; Cohen, A. D.; Hamadene, L.; Rizzuto, G. A.; Budhu, S.; Suek, N.; more...
    JCI Insight (2021)

    Fulltext@MSK | Save
  • Treatment with agonist anti-GITR antibody after chemotherapy enhances tumor immunity
    Meeting Abstract

    Warner, A. B.; Hirschhorn, D.; Cohen, A.; Liu, C.; Newman, W.; Sirard, C.; Wolchok, J.; Merghoub, T.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Enhanced responses to tumor immunization following total body irradiation are time-dependent
    Journal Article

    Diab, A.; Jenq, R. R.; Rizzuto, G. A.; Cohen, A. D.; Huggins, D. W.; Merghoub, T.; Engelhorn, M. E.; Guevara-Patiño, J. A.; Suh, D.; Hubbard-Lucey, V. M.; more...
    PLoS ONE (2013)

    Fulltext@MSK | Save
  • Detection of intra-tumor self antigen recognition during melanoma tumor progression in mice using advanced multimode confocal/two photon microscope
    Journal Article

    Schaer, D. A.; Li, Y.; Merghoub, T.; Rizzuto, G. A.; Shemesh, A.; Cohen, A. D.; Avogadri, F.; Toledo-Crow, R.; Houghton, A. N.; Wolchok, J. D.
    PLoS ONE (2011)

    Fulltext@MSK | Save
  • Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation
    Journal Article

    Cohen, A. D.; Schaer, D. A.; Liu, C.; Li, Y.; Hirschhorn-Cymmerman, D. ; Kim, S. C.; Diab, A.; Rizzuto, G.; Duan, F.; Perales, M. A.; more...
    PLoS ONE (2010)

    Fulltext@MSK | Save
  • FDG PET/CT (FDG PET) in evaluation of response in patients with multiple myeloma (MM) treated with bortezomib, pegylated liposomal doxorubicin, and dexamethasone
    Meeting Abstract

    Pandit-Taskar, N.; Comenzo, R. L.; Hassoun, H.; Hoover, E.; Borkar, S.; Reidel, E.; Cohen, A.; Surti, C.; Nimer, S. D.; Landau, H. J.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Adjuvant bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in patients with light-chain amyloidosis (AL)
    Meeting Abstract

    Landau, H. J.; Hoffman, J.; Hassoun, H.; Elizabeth, H.; Riedel, E.; Nimer, S. D.; Cohen, A.; Comenzo, R. L.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis
    Journal Article

    Hirschhorn-Cymerman, D.; Rizzuto, G. A.; Merghoub, T.; Cohen, A. D.; Avogadri, F.; Lesokhin, A. M.; Weinberg, A. D.; Wolchok, J. D.; Houghton, A. N.
    Journal of Experimental Medicine (2009)

    Fulltext@MSK | Save
  • Immune rejection of mouse tumors expressing mutated self
    Journal Article

    Duan, F.; Lin, Y.; Liu, C.; Engelhorn, M. E.; Cohen, A. D.; Curran, M.; Sakaguchi, S.; Merghoub, T.; Terzulli, S.; Wolchok, J. D.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Risk-adapted melphalan with stem cell transplant (SCT) and adjuvant dexamethasone (dex) +/- thalidomide (thal) achieves low treatment related mortality and high hematologic response rates
    Book Section

    Cohen, A. D.; Zhou, P.; Reich, L.; Hassoun, H.; Teruya-Feldstein, J.; Filippa, D. A.; Clark, B.; Stubblefield, M.; Fleisher, M.; Nimer, S. D.; more...
    In Skinner, M.; Berk, J. L.; Connors, L. H.; Seldin, D. C. (Eds.) XIth International Symposium on Amyloidosis (2008)

    Fulltext@MSK | Save